Akèy › Anemi
Etid klinik pou Anemi ap rekrite nan Etazini
29 etid pou Anemi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY7 etid
- Philadelphia, PA6 etid
- Atlanta, GA6 etid
- Miami, FL6 etid
- Tampa, FL5 etid
- Houston, TX5 etid
- Winston-Salem, NC4 etid
- Baldwin Park, CA4 etid
- St. Louis, MO4 etid
- Cleveland, OH4 etid
- Seattle, WA3 etid
- Edison, NJ3 etid
- Los Angeles, CA3 etid
- Portland, OR3 etid
- Gilbert, AZ3 etid
- The Woodlands, TX3 etid
- Nashville, TN3 etid
- Queens, NY3 etid
- Washington, DC3 etid
- Orlando, FL3 etid
Pa eta
- Arizona4 etid
- Florid9 etid
- Georgia7 etid
- Kalifòni8 etid
- Maryland3 etid
- Minnesota3 etid
- Missouri6 etid
- New Jersey3 etid
- New York11 etid
- North Carolina5 etid
- Ohio6 etid
- Oregon3 etid
- Pennsylvania7 etid
- Tennessee4 etid
- Texas7 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07623161Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198Study of DISC-0974-201 in Participants With IBD and Anemia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07368972A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07422480A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06499285A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Ap rekriteEtid obsèvasyon
1 Month – 100 Years · Tout sèks · Mizajou Aug 19, 2026 · NCT06092346T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Ap rekriteFaz 1/2
Laj 5 a 40 · Tout sèks · Mizajou Aug 13, 2026 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Ap rekriteFaz 3
Laj 2 a 18 · Tout sèks · Mizajou Aug 7, 2026 · NCT06934967Choline and Iron Deficiency
Ap rekriteFaz 2/3
5 Months – 7 Months · Tout sèks · Mizajou Aug 5, 2026 · NCT06527391Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07224360A Study of Luspatercept in People With Anemia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07725497Kids With Iron Deficiency and Scoliosis
Ap rekriteVolontè an sante akeyi
Laj 10 a 26 · Tout sèks · Mizajou Jun 26, 2026 · NCT06042699Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Jun 17, 2026 · NCT06106269131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Ap rekriteFaz 1
Laj 12 a 50 · Tout sèks · Mizajou Jun 10, 2026 · NCT07015684Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Ap rekriteFaz 2
3 Days · Tout sèks · Mizajou May 26, 2026 · NCT05340465Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05800600Therapeutic RSK1 Targeting in Myelofibrosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07379125Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT07281781A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Apr 17, 2026 · NCT03893045Diamond Blackfan Anemia Registry (DBAR)
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 16, 2026 · NCT00106015Luspatercept for Clonal Cytopenias of Uncertain Significance
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT06788691Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Feb 18, 2026 · NCT06979492The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Feb 6, 2026 · NCT06606119129Xe MRI Cardiopulmonary
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT06038630A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 30, 2025 · NCT05735314Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.